Results 221 to 230 of about 29,708 (286)

Is There an Industry Effect of SPAC Merger Announcements?

open access: yesEuropean Financial Management, Volume 32, Issue 2, Page 565-586, March 2026.
ABSTRACT This study investigates whether SPAC merger announcements affect the target firms' industry rivals. Using a sample of 468 SPAC mergers from 2016 to 2023, the results indicate that rival firms experience significant negative abnormal returns, especially around smaller and riskier deals that yield lower announcement returns for SPACs. Additional
Carene Boucher
wiley   +1 more source

Plasma C‐reactive protein and interleukin‐6 concentrations in foals during health and respiratory disease

open access: yesEquine Veterinary Journal, Volume 58, Issue 2, Page 372-379, March 2026.
Abstract Background Early and specific diagnosis of bronchopneumonia in foals is important to prevent severe disease. In human medicine, C‐reactive protein (CRP) and interleukin‐6 (IL‐6) are important diagnostic and prognostic biomarkers in neonatal pneumonia in other species.
Dorothea Hildebrandt   +3 more
wiley   +1 more source

The potential value of cytokine, cortisol and vitamin D profiles in foals from birth to weaning for respiratory disease prediction on a farm endemic for Rhodococcus equi pneumonia

open access: yesEquine Veterinary Journal, Volume 58, Issue 2, Page 359-371, March 2026.
Abstract Background Rhodococcus equi causes pneumonia in young foals, but disease susceptibility and severity vary. Cortisol and vitamin D modulate immune responses and cytokine production during bacterial infection, and altered concentrations are associated with sepsis in neonatal foals. We hypothesised an age and disease effect on circulating steroid
Londa J. Berghaus   +4 more
wiley   +1 more source

Lung organoids as a human system for Mycobacteria infection modeling and drug testing

open access: yesThe FEBS Journal, Volume 293, Issue 6, Page 1587-1611, March 2026.
Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy